As of October 9, 2026, Lilly(Eli) & Co (LLY) is trading at $1174.49. BlackOwl's AI analysis indicates a bullish outlook with 70% confidence and a price target of $1210.00 (3.0% above the current price).
LLY
$1174.49 bullishLilly(Eli) & Co
Over a 2-week timeframe, LLY benefits from robust operational metrics and strong market positioning in metabolic treatments. The target of $1210 reflects sustained fundamental momentum.
Trend
Confidence
70%
Price Target
$1210.00
+3.0% from current
Timeframe
2 Weeks
Until 10/20/2026
Key Insights
- Medium-term trend supported by exceptional fundamentals including a 44.7% revenue jump
- Consolidation above moving averages signals building pressure for a leg higher
Risk Factors
- Sector-wide rotation could constrain pharmaceutical multiple expansions
- Elevated expectations regarding next-generation treatments
Actionable Items
- Accumulate positions during minor pullbacks toward the 20-day moving average
- Monitor broader healthcare sector flows and competitor updates
News Sentiment
News Count
5
Impact Level
medium
Sentiment
Positive
Key Topics
RSI (14)
53.2
MACD
0.462
EMA
$1164.52
Price above EMA
SMA
$1161.13
Price above SMA
Historical Comparison
Key Statistics
New to reading these? Start with how to research stocks.
Related Tickers
Frequently Asked Questions
What is Lilly(Eli) & Co's current stock price?
What does BlackOwl's AI model project for LLY?
What is LLY's P/E ratio?
How do I buy LLY stock?
Get AI-powered insights for LLY
Unlock real-time signals, personalized risk analysis, and trade recommendations.
Try BlackOwl Free